BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18524870)

  • 21. Hypoglycemia with enhanced hepatic glycogen synthesis in recombinant mice lacking hexose-6-phosphate dehydrogenase.
    Lavery GG; Hauton D; Hewitt KN; Brice SM; Sherlock M; Walker EA; Stewart PM
    Endocrinology; 2007 Dec; 148(12):6100-6. PubMed ID: 17823265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.
    Gomez-Sanchez EP; Romero DG; de Rodriguez AF; Warden MP; Krozowski Z; Gomez-Sanchez CE
    Endocrinology; 2008 Feb; 149(2):525-33. PubMed ID: 18039793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of 11β-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor by ethanol in rat liver and mouse hepatoma cells.
    Meng Z; Bao X; Zhang M; Wei S; Chang W; Li J; Chen L; Nyomba BL
    J Diabetes Res; 2013; 2013():218102. PubMed ID: 23819126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH.
    Abrahams L; Semjonous NM; Guest P; Zielinska A; Hughes B; Lavery GG; Stewart PM
    J Endocrinol; 2012 Sep; 214(3):367-72. PubMed ID: 22718432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue.
    Bujalska IJ; Hewitt KN; Hauton D; Lavery GG; Tomlinson JW; Walker EA; Stewart PM
    Endocrinology; 2008 May; 149(5):2584-91. PubMed ID: 18218694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced prereceptor glucocorticoid metabolism and lipogenesis impair insulin signaling in the liver of fructose-fed rats.
    Vasiljević A; Veličković N; Bursać B; Djordjevic A; Milutinović DV; Nestorović N; Matić G
    J Nutr Biochem; 2013 Nov; 24(11):1790-7. PubMed ID: 23773625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis.
    Zhang YL; Zhong X; Gjoka Z; Li Y; Stochaj W; Stahl M; Kriz R; Tobin JF; Erbe D; Suri V
    Arch Biochem Biophys; 2009 Mar; 483(1):45-54. PubMed ID: 19121282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.
    Liu Y; Yan C; Wang Y; Nakagawa Y; Nerio N; Anghel A; Lutfy K; Friedman TC
    Endocrinology; 2006 Nov; 147(11):5061-8. PubMed ID: 16873540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
    Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring.
    Nyirenda MJ; Lindsay RS; Kenyon CJ; Burchell A; Seckl JR
    J Clin Invest; 1998 May; 101(10):2174-81. PubMed ID: 9593773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
    Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
    J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
    Park SB; Jung WH; Kang NS; Park JS; Bae GH; Kim HY; Rhee SD; Kang SK; Ahn JH; Jeong HG; Kim KY
    Eur J Pharmacol; 2013 Dec; 721(1-3):70-9. PubMed ID: 24135201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
    Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
    Liu J; Wang L; Zhang A; Di W; Zhang X; Wu L; Yu J; Zha J; Lv S; Cheng P; Hu M; Li Y; Qi H; Ding G; Zhong Y
    Endocr J; 2011; 58(3):199-209. PubMed ID: 21325744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
    Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
    Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
    Véniant MM; Hale C; Komorowski R; Chen MM; St Jean DJ; Fotsch C; Wang M
    Diabetes Obes Metab; 2009 Feb; 11(2):109-17. PubMed ID: 18479468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.